Change search
Link to record
Permanent link

Direct link
Publications (3 of 3) Show all publications
Czwakiel, P., Brindefalk, B., Eghbali, A., Dircksen, H., Kamal, K., Payandeh, Z., . . . Faye, I. (2025). Sex Dependent and Sjögren Disease Like Immune Responses Against Phosphoantigens in Balb/C Mice. Scandinavian Journal of Immunology, 102(3), Article ID e70052.
Open this publication in new window or tab >>Sex Dependent and Sjögren Disease Like Immune Responses Against Phosphoantigens in Balb/C Mice
Show others...
2025 (English)In: Scandinavian Journal of Immunology, ISSN 0300-9475, E-ISSN 1365-3083, Vol. 102, no 3, article id e70052Article in journal (Refereed) Published
Abstract [en]

The initial aim of this study on Balb/C mice was to investigate the putative effects on feeding and appetite of isopentenyl pyrophosphate (IPP) and E-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMBPP), also known as phosphoantigens (pAgs). HMBPP was recently shown to increase blood meal appetite in malaria mosquitoes. Both IPP and HMBPP are metabolites produced by the normal gut microbiota and apicomplexan parasites such as Plasmodium. To explore potential effects on appetite, male and female mice were treated by gavage with these metabolites, and body mass and gene expression were monitored in brain, stomach and small intestine at 3 h and 7 weeks. Body mass gain did not clearly differ between pAg-treated and water control mice. However, beginning between 4 and 7 weeks, the salivary glands of IPP-treated males began to swell. With the autoimmune Sjögren disease (SjD) in mind, we subsequently investigated the salivary glands after 1, 4 and 7 weeks of IPP treatment. Fast gene set enrichment analysis (FGSEA) of marginal zone B-cell (MZB) transcripts from salivary glands, together with B-cell infiltration in both sexes at 4 weeks, suggested similarities to SjD pathology. Using ELISA, we measured serum autoantibodies against Ro52, Ro60 and La. Multivariate analysis at 7 weeks showed treatment-associated trends: levels of anti-Ro52 and anti-La tended to increase in IPP-treated males, but not in females. Notably, IL-6 serum levels displayed a sex-dependent pattern, and PCA analyses of transcriptomic data from brain, stomach and small intestine—though with some exceptions—also indicated differential responses to pAgs between males and females.

Keywords
auto-antibodies, Balb/C mice, E-4-hydroxy-3methyl-but-2-enyl pyrophosphate, isopentenyl pyrophosphate, marginal zone B-cell transcription, salivary glands, sex-dependent immune response, Sjögren disease, transcriptomics
National Category
Immunology
Identifiers
urn:nbn:se:su:diva-247348 (URN)10.1111/sji.70052 (DOI)001579051300002 ()40898584 (PubMedID)2-s2.0-105015079001 (Scopus ID)
Available from: 2025-09-24 Created: 2025-09-24 Last updated: 2025-10-03Bibliographically approved
Yu, T., Biasini, A., Cecchini, K., Säflund, M., Mou, H., Arif, A., . . . Özata, D. M. (2023). A-MYB/TCFL5 regulatory architecture ensures the production of pachytene piRNAs in placental mammals. RNA: A publication of the RNA Society, 29(1), 30-43
Open this publication in new window or tab >>A-MYB/TCFL5 regulatory architecture ensures the production of pachytene piRNAs in placental mammals
Show others...
2023 (English)In: RNA: A publication of the RNA Society, ISSN 1355-8382, E-ISSN 1469-9001, Vol. 29, no 1, p. 30-43Article in journal (Refereed) Published
Abstract [en]

In male mice, the transcription factor A-MYB initiates the transcription of pachytene piRNA genes during meiosis. Here, we report that A-MYB activates the transcription factor Tcfl5 produced in pachytene spermatocytes. Subsequently, A-MYB and TCFL5 reciprocally reinforce their own transcription to establish a positive feedback circuit that triggers pachytene piRNA production. TCFL5 regulates the expression of genes required for piRNA maturation and promotes transcription of evolutionarily young pachytene piRNA genes, whereas A-MYB activates the transcription of older pachytene piRNA genes. Intriguingly, pachytene piRNAs from TCFL5-dependent young loci initiate the production of piRNAs from A-MYB-dependent older loci, ensuring the self-propagation of pachytene piRNAs. A-MYB and TCFL5 act via a set of incoherent feedforward loops that drive regulation of gene expression by pachytene piRNAs during spermatogenesis. This regulatory architecture is conserved in rhesus macaque, suggesting that it was present in the last common ancestor of placental mammals.

Keywords
TCFL5, A-MYB, pachytene piRNAs, spermatogenesis
National Category
Developmental Biology
Identifiers
urn:nbn:se:su:diva-224632 (URN)10.1261/rna.079472.122 (DOI)001103526200003 ()36241367 (PubMedID)2-s2.0-85146000742 (Scopus ID)
Available from: 2023-12-20 Created: 2023-12-20 Last updated: 2023-12-20Bibliographically approved
Cecchini, K., Biasini, A., Yu, T., Säflund, M., Mou, H., Arif, A., . . . Ozata, D. (2023). The transcription factor TCFL5 responds to A-MYB to elaborate the male meiotic program in mice. Reproduction, 165(2), 183-196
Open this publication in new window or tab >>The transcription factor TCFL5 responds to A-MYB to elaborate the male meiotic program in mice
Show others...
2023 (English)In: Reproduction, ISSN 1470-1626, E-ISSN 1476-3990, Vol. 165, no 2, p. 183-196Article in journal (Refereed) Published
Abstract [en]

In male mice, the transcription factors STRA8 and MEISON initiate meiosis I. We report that STRA8/MEISON activates the transcription factors A-MYB and TCFL5, which together reprogram gene expression after spermatogonia enter into meiosis. TCFL5 promotes the transcription of genes required for meiosis, mRNA turnover, miR-34/449 production, meiotic exit, and spermiogenesis. This transcriptional architecture is conserved in rhesus macaque, suggesting TCFL5 plays a central role in meiosis and spermiogenesis in placental mammals. Tcfl5(em1/em1) mutants are sterile, and spermatogenesis arrests at the mid- or late-pachytene stage of meiosis. Moreover, Tcfl5(+/em1) mutants produce fewer motile sperm.

National Category
Biological Sciences
Identifiers
urn:nbn:se:su:diva-215951 (URN)10.1530/REP-22-0355 (DOI)000941396200007 ()36395073 (PubMedID)2-s2.0-85145492027 (Scopus ID)
Available from: 2023-03-29 Created: 2023-03-29 Last updated: 2023-03-29Bibliographically approved
Organisations
Identifiers
ORCID iD: ORCID iD iconorcid.org/0009-0009-7291-1616

Search in DiVA

Show all publications